CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
December 2014—Roche and ARK Diagnostics announced a distribution agreement that will enable laboratories to integrate ARK’s Methotrexate test into the Roche therapeutic drug monitoring menu for its Cobas c 501 and Cobas c 502 clinical chemistry analyzers. The TDM Methotrexate Cobas c test kits are used to provide information to help health care professionals manage patients on cancer drug therapy.
Roche Diagnostics, +41 41 79 85990